EnteroMedics Company Profile (NASDAQ:ETRM)

About EnteroMedics (NASDAQ:ETRM)

EnteroMedics logoEnteroMedics Inc. (EnteroMedics) is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company's neuroblocking technology, which is referred to as VBLOC therapy, is designed to intermittently block the vagus nerve. The Company's initial product is the Maestro Rechargeable System, which uses VBLOC therapy to limit the expansion of the stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The Company's VBLOC therapy is designed to block the gastrointestinal effects of the vagus nerve by replicating a vagotomy using high-frequency, low-energy electrical impulses to intermittently interrupt naturally occurring neural impulses on the vagus nerve between the brain and the digestive system.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:ETRM
  • CUSIP: 29365M20
  • Web: www.enteromedics.com
Capitalization:
  • Market Cap: $18.73 million
  • Outstanding Shares: 8,294,000
Average Prices:
  • 50 Day Moving Avg: $2.30
  • 200 Day Moving Avg: $4.38
  • 52 Week Range: $0.04 - $30.41
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.51
  • P/E Growth: -4.33
Sales & Book Value:
  • Annual Revenue: $571,759.00
  • Price / Sales: 29.45
  • Book Value: $4.58 per share
  • Price / Book: 0.44
Profitability:
  • EBIDTA: ($22,150,000.00)
  • Net Margins: -4,399.48%
  • Return on Equity: -167.73%
  • Return on Assets: -123.00%
Debt:
  • Current Ratio: 2.95%
  • Quick Ratio: 2.63%
Misc:
  • Average Volume: 298,725 shs.
  • Beta: 3.08
  • Short Ratio: 5.33
 

Frequently Asked Questions for EnteroMedics (NASDAQ:ETRM)

What is EnteroMedics' stock symbol?

EnteroMedics trades on the NASDAQ under the ticker symbol "ETRM."

When did EnteroMedics' stock split? How did EnteroMedics' stock split work?

EnteroMedics shares reverse split on the morning of Friday, January 8th 2016. The 1-15 reverse split was announced on Wednesday, December 23rd 2015. The number of shares owned by shareholders was adjusted after the market closes on Thursday, January 7th 2016. An investor that had 100 shares of EnteroMedics stock prior to the reverse split would have 7 shares after the split.

How were EnteroMedics' earnings last quarter?

EnteroMedics Inc. (NASDAQ:ETRM) issued its quarterly earnings results on Tuesday, August, 8th. The company reported ($0.91) earnings per share for the quarter, beating the Zacks' consensus estimate of ($1.00) by $0.09. The firm earned $0.09 million during the quarter, compared to analysts' expectations of $0.20 million. EnteroMedics had a negative net margin of 4,399.48% and a negative return on equity of 167.73%. View EnteroMedics' Earnings History.

When will EnteroMedics make its next earnings announcement?

EnteroMedics is scheduled to release their next quarterly earnings announcement on Thursday, November, 9th 2017. View Earnings Estimates for EnteroMedics.

Where is EnteroMedics' stock going? Where will EnteroMedics' stock price be in 2017?

1 brokers have issued 12-month price targets for EnteroMedics' shares. Their predictions range from $11.00 to $11.06. On average, they expect EnteroMedics' stock price to reach $11.03 in the next year. View Analyst Ratings for EnteroMedics.

Are investors shorting EnteroMedics?

EnteroMedics saw a decline in short interest in August. As of August 31st, there was short interest totalling 879,769 shares, a decline of 37.0% from the August 15th total of 1,396,751 shares. Based on an average daily volume of 311,002 shares, the days-to-cover ratio is presently 2.8 days. Currently, 9.6% of the shares of the company are sold short.

Who are some of EnteroMedics' key competitors?

Who are EnteroMedics' key executives?

EnteroMedics' management team includes the folowing people:

  • Dan W. Gladney, Chairman of the Board, President, Chief Executive Officer
  • Scott P. Youngstrom, Chief Financial Officer, Chief Compliance Officer
  • Naqeeb Ansari, Senior Vice President - Sales
  • Paul Hickey, Senior Vice President - Marketing and Reimbursement
  • Peter M. Delange, Senior Vice President - Operations and Business Development
  • Adrianus Donders, Senior Vice President - Research and Advanced Development
  • Katherine S. Tweden Ph.D., Senior Vice President - Research
  • Tonya Dowd, Vice President - Reimbursement
  • Gary D. Blackford, Director
  • Lori Courtney McDougal, Director

Who owns EnteroMedics stock?

EnteroMedics' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (0.72%). Company insiders that own EnteroMedics stock include Carl Goldfischer and Peter M Delange. View Institutional Ownership Trends for EnteroMedics.

Who bought EnteroMedics stock? Who is buying EnteroMedics stock?

EnteroMedics' stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc.. View Insider Buying and Selling for EnteroMedics.

How do I buy EnteroMedics stock?

Shares of EnteroMedics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is EnteroMedics' stock price today?

One share of EnteroMedics stock can currently be purchased for approximately $2.03.


MarketBeat Community Rating for EnteroMedics (NASDAQ ETRM)
Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  130 (Vote Outperform)
Underperform Votes:  84 (Vote Underperform)
Total Votes:  214
MarketBeat's community ratings are surveys of what our community members think about EnteroMedics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for EnteroMedics (NASDAQ:ETRM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.03 (443.35% upside)

Analysts' Ratings History for EnteroMedics (NASDAQ:ETRM)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/25/2017Ladenburg Thalmann Financial ServicesReiterated RatingBuy$11.00LowView Rating Details
1/9/2017S&P Equity ResearchLower Price Target$17.19 -> $11.06N/AView Rating Details
6/9/2016Roth CapitalDowngradeBuy -> Neutral$3.00 -> $3.00N/AView Rating Details
11/10/2015Canaccord GenuityLower Price Target$37.50 -> $15.00N/AView Rating Details
(Data available from 9/23/2015 forward)

Earnings

Earnings History for EnteroMedics (NASDAQ:ETRM)
Earnings by Quarter for EnteroMedics (NASDAQ:ETRM)
Earnings History by Quarter for EnteroMedics (NASDAQ ETRM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2017        
8/8/2017Q2 2017($1.00)($0.91)$0.20 million$0.09 millionViewListenView Earnings Details
5/16/2017Q1 2017($0.63)($1.27)$0.04 millionViewN/AView Earnings Details
3/7/2017Q4 2016($0.44)($2.65)$0.14 millionViewN/AView Earnings Details
11/10/2016Q3 2016($0.50)($0.17)$0.34 million$0.30 millionViewN/AView Earnings Details
8/4/2016Q216($0.75)($0.49)$0.19 million$0.28 millionViewN/AView Earnings Details
2/17/2016Q315($0.90)($0.95)$0.43 million$0.15 millionViewListenView Earnings Details
8/6/2015Q215($0.10)($0.10)$0.06 million$0.08 millionViewN/AView Earnings Details
2/18/2015Q414($0.10)($0.09)ViewN/AView Earnings Details
11/12/2014Q3 14($0.10)($0.08)ViewN/AView Earnings Details
8/7/2014Q2($0.10)($0.11)ViewListenView Earnings Details
4/30/2014Q1 14($0.10)($0.10)ViewN/AView Earnings Details
2/12/2014Q413($0.10)($0.11)ViewN/AView Earnings Details
10/31/2013Q313($0.11)($0.11)ViewN/AView Earnings Details
7/31/2013Q2 2013($0.13)($0.11)ViewN/AView Earnings Details
5/1/2013Q1 2013($0.13)($0.14)$0.10 millionViewN/AView Earnings Details
2/13/2013Q4 2012($0.14)($0.17)$0.36 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for EnteroMedics (NASDAQ:ETRM)
Current Year EPS Consensus Estimate: $-1.77 EPS
Next Year EPS Consensus Estimate: $-0.81 EPS

Dividends

Dividend History for EnteroMedics (NASDAQ:ETRM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for EnteroMedics (NASDAQ:ETRM)
Insider Ownership Percentage: 5.50%
Institutional Ownership Percentage: 1.28%
Insider Trades by Quarter for EnteroMedics (NASDAQ:ETRM)
Institutional Ownership by Quarter for EnteroMedics (NASDAQ:ETRM)
Insider Trades by Quarter for EnteroMedics (NASDAQ:ETRM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/25/2017Carl GoldfischerDirectorSell4,668$4.85$22,639.80View SEC Filing  
6/3/2016Peter M DelangeSVPBuy20,000$0.55$11,000.00View SEC Filing  
8/13/2015Mark B KnudsonCEOBuy303,000$0.25$75,750.00View SEC Filing  
6/19/2014Cathy FriedmanDirectorBuy11,800$1.70$20,060.00View SEC Filing  
1/8/2014Luke EvninDirectorSell556,585$2.50$1,391,462.50View SEC Filing  
2/27/2013Anthony P JanszDirectorBuy150,000$0.95$142,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for EnteroMedics (NASDAQ:ETRM)
Latest Headlines for EnteroMedics (NASDAQ:ETRM)
Source:
DateHeadline
americanbankingnews.com logoEnteroMedics Inc. (ETRM) Short Interest Down 37.0% in August
www.americanbankingnews.com - September 16 at 1:44 AM
americanbankingnews.com logoComparing EnteroMedics (ETRM) and The Competition
www.americanbankingnews.com - September 13 at 4:26 AM
finance.yahoo.com logoEnteroMedics to Present at the Ladenburg Thalmann 2017 Healthcare Conference
finance.yahoo.com - September 12 at 7:15 PM
finance.yahoo.com logoShould You Buy EnteroMedics Inc (ETRM)?
finance.yahoo.com - September 12 at 12:03 AM
finance.yahoo.com logoEnteroMedics Begins Post-Approval Study for the Treatment of Obesity with vBloc Therapy
finance.yahoo.com - September 5 at 8:05 PM
americanbankingnews.com logoValuEngine Upgrades EnteroMedics Inc. (ETRM) to Sell
www.americanbankingnews.com - September 3 at 1:26 PM
finance.yahoo.com logoStudy Concludes Vagal Nerve Blocking with EnteroMedics' vBloc Therapy is Cost-Effective
finance.yahoo.com - August 28 at 6:11 PM
finance.yahoo.com logoEnteroMedics, Inc. :ETRM-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017
finance.yahoo.com - August 24 at 7:30 PM
americanbankingnews.com logoEnteroMedics Inc. (ETRM) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - August 23 at 5:58 PM
finance.yahoo.com logoEnteroMedics Announces First Veterans Choice Program vBloc® Implant at MedStar Health in Maryland
finance.yahoo.com - August 21 at 6:00 PM
finance.yahoo.com logoEnteroMedics Announces Presentations Highlighting vBloc and Gastric Vest at IFSO Annual Conference
finance.yahoo.com - August 16 at 9:35 PM
prnewswire.com logoEnteroMedics Announces Presentations Highlighting vBloc and Gastric Vest at IFSO Annual Conference - PR Newswire (press release)
www.prnewswire.com - August 16 at 4:33 PM
streetinsider.com logoEnteroMedics (ETRM) Prices $20M Public Offering of Preferred Stock, Warrants
www.streetinsider.com - August 12 at 4:55 AM
benzinga.com logoMid-Afternoon Market Update: Luxoft Drops On Disappointing Q1 Results; DryShips Shares Surge - Benzinga
www.benzinga.com - August 11 at 11:55 PM
seekingalpha.com logoEnteroMedics readies equity offering; shares down 29% premarket - Seeking Alpha
seekingalpha.com - August 11 at 11:54 PM
finance.yahoo.com logoEnteroMedics Announces Pricing of $20 Million Underwritten Public Offering
finance.yahoo.com - August 11 at 6:53 PM
finance.yahoo.com logoEnteroMedics Announces Proposed Underwritten Public Offering
finance.yahoo.com - August 10 at 7:46 PM
seekingalpha.com logoEnteroMedics' (ETRM) CEO Dan Gladney on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 11:37 PM
finance.yahoo.com logoEdited Transcript of ETRM earnings conference call or presentation 8-Aug-17 3:30pm GMT
finance.yahoo.com - August 9 at 11:36 PM
finance.yahoo.com logoEnteroMedics Announces Second Quarter 2017 Financial Results
finance.yahoo.com - August 8 at 6:11 PM
finance.yahoo.com logoInvestor Network: EnteroMedics Inc. to Host Earnings Call
finance.yahoo.com - August 8 at 6:11 PM
finance.yahoo.com logoEnteroMedics reports 2Q loss
finance.yahoo.com - August 8 at 6:11 PM
americanbankingnews.com logoEnteroMedics Inc. (ETRM) Issues Earnings Results
www.americanbankingnews.com - August 8 at 12:46 PM
americanbankingnews.com logoEnteroMedics (NASDAQ:ETRM) and Synergetics USA (SURG) Head to Head Analysis
www.americanbankingnews.com - August 7 at 12:12 PM
americanbankingnews.com logoEnteroMedics Inc. (ETRM) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - August 3 at 10:58 AM
finance.yahoo.com logoEnteroMedics To Discuss Business Strategy And Financial Results For The Second Quarter Of 2017
finance.yahoo.com - August 2 at 7:18 PM
benzinga.com logo22 Stocks Moving In Monday's Pre-Market Session | Benzinga - Benzinga
www.benzinga.com - August 1 at 7:03 PM
finance.yahoo.com logoEnteroMedics Receives Approval for Gastric Vest System Clinical Study in Spain
finance.yahoo.com - July 31 at 6:08 PM
benzinga.com logo18 Biggest Mid-Day Gainers For Wednesday | Benzinga - Benzinga
www.benzinga.com - July 26 at 7:02 PM
nasdaq.com logoMid-Morning Market Update: Markets Open Higher; Ford Profit Beats ... - Nasdaq
www.nasdaq.com - July 26 at 7:02 PM
streetinsider.com logoEnteroMedics (ETRM) Reports First Veterans Choice Program vBloc Implant for Obesity at Methodist Dallas Medical Center (Earlier)
www.streetinsider.com - July 25 at 11:45 PM
streetinsider.com logoEnteroMedics (ETRM) Reports First Veterans Choice Program vBloc Implant for Obesity at Methodist Dallas Medical ... - StreetInsider.com
www.streetinsider.com - July 25 at 6:43 PM
streetinsider.com logoEnteroMedics (ETRM) Enters Collaboration Agreement with Galvani Bioelectronics - StreetInsider.com
www.streetinsider.com - July 25 at 6:43 PM
finance.yahoo.com logoEnteroMedics Announces First Veterans Choice Program vBloc® Implant for Obesity at Methodist Dallas Medical Center
finance.yahoo.com - July 25 at 6:43 PM
americanbankingnews.com logoZacks Investment Research Upgrades EnteroMedics Inc. (NASDAQ:ETRM) to "Buy"
www.americanbankingnews.com - July 21 at 6:12 PM
streetinsider.com logoEnteroMedics (ETRM) Receives European Patent Certificate - StreetInsider.com
www.streetinsider.com - July 20 at 9:03 PM
americanbankingnews.com logoEnteroMedics Inc. (ETRM) Downgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - July 20 at 9:02 PM
streetinsider.com logoEnteroMedics (ETRM) Receives European Patent Certificate
www.streetinsider.com - July 20 at 4:01 PM
finance.yahoo.com logoEnteroMedics Announces Receipt of European Patent Certificate
finance.yahoo.com - July 20 at 4:01 PM
americanbankingnews.com logoEnteroMedics Inc. (NASDAQ:ETRM) Downgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - July 14 at 12:05 AM
americanbankingnews.com logoEnteroMedics Inc. (NASDAQ:ETRM) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - July 12 at 5:58 PM
finance.yahoo.com logoEnteroMedics Announces Affordable vBloc® Therapy Program for Weight Loss Patients
finance.yahoo.com - June 28 at 6:08 PM
prnewswire.com logoEnteroMedics Added to Russell Microcap® Index - PR Newswire (press release)
www.prnewswire.com - June 26 at 9:38 AM
finance.yahoo.com logoEnteroMedics Added to Russell Microcap® Index
finance.yahoo.com - June 26 at 9:38 AM
prnewswire.com logoEnteroMedics Announces vBloc Therapy to be Presented by ... - PR Newswire (press release)
www.prnewswire.com - June 21 at 6:35 PM
finance.yahoo.com logoEnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference
finance.yahoo.com - June 21 at 6:35 PM
finance.yahoo.com logoEdited Transcript of ETRM earnings conference call or presentation 7-Mar-17 4:00pm GMT
finance.yahoo.com - June 7 at 4:30 PM
finance.yahoo.com logoEnteroMedics, Inc. :ETRM-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017
finance.yahoo.com - June 2 at 6:23 PM
streetinsider.com logoEnteroMedics (ETRM) Reports First vBloc Neurometabolic Therapy Implant at AMITA Health Adventist Medical Center Bolingbrook
www.streetinsider.com - May 31 at 5:01 PM
seekingalpha.com logoEnteroMedics announces first vBloc implant at Illinois hospital; shares up 3%
seekingalpha.com - May 31 at 10:43 AM

Social

Chart

EnteroMedics (ETRM) Chart for Saturday, September, 23, 2017

This page was last updated on 9/23/2017 by MarketBeat.com Staff